AgeX Therapeutics, Inc. (24) | Facility Agreements (3)
Recent Contracts
-
Second Amendment to Secured Convertible Facility Agreement, dated November 12, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on November 16, 2020)
-
First Amendment to Secured Convertible Facility Agreement, dated July 21, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited
(Filed With SEC on August 14, 2020)
-
Secured Convertible Facility Agreement, dated March 30, 2020, by and among AgeX Therapeutics, Inc., ReCyte Therapeutics, Inc., Reverse Bioengineering, Inc., and Juvenescence...
(Filed With SEC on March 30, 2020)
